The physiotherapist’s role in the SARS-CoV-2 pandemic

Authors

  • Maria Teresa Tomás Departamento das Ciências da Terapia e Reabilitação, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal. H&TRC – Health & Technology Research Center, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Germano Ferreira Departamento das Ciências da Terapia e Reabilitação, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal. Hospital de S. José. Lisboa, Portugal.
  • Beatriz Fernandes Departamento das Ciências da Terapia e Reabilitação, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal. H&TRC – Health & Technology Research Center, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.

DOI:

https://doi.org/10.25758/set.2271

Keywords:

COVID-19, Acute respiratory distress syndrome, Respiratory physiotherapy

Abstract

The disease COVID-19 caused by the coronavirus SARS-CoV-2 translates, in individuals affected by this virus, from mild respiratory symptoms, sometimes imperceptible to serious respiratory and multiorgan implications, especially if associated with risk groups such as people with hypertension, diabetes, or those with more than 65 years, among others. For the most severely affected patients, hospitalization in intensive care units due to severe respiratory distress syndrome may be a reality, with increased hospitalization time compared to normal pneumonia, which will translate into the motor and functional sequelae where the physiotherapist will have an essential role to develop. In any of the different stages of evolution of this disease (critical and acute, post-acute, ambulatory, and home), the physiotherapist acts in order to restore maximum functional capacity in individuals affected by COVID-19. The purpose of this text is thus to show the role of the physiotherapist in each of these intervention stages.

Downloads

Download data is not yet available.

References

Rello J, Storti E, Belliato M, Serrano R. Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers. Eur Respir J. 2020 May;55(5):2001028.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612-4.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-9.

Dinglas VD, Friedman LA, Colantuoni E, Mendez-Tellez PA, Shanholtz CB, Ciesla ND, et al. Muscle weakness and 5-year survival in acute respiratory distress syndrome survivors. Crit Care Med. 2017;45(3):446-53.

Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, et al. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020;66(2):73-82.

Vitacca M, Carone M, Clini EM, Paneroni M, Lazzeri M, Lanza A, et al. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration. 2020;99(6):493-9.

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87.

Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A, et al. Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a position paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020;90(1):163-8.

Miranda-Rocha AR, Martinez BP, Maldaner-da-Silva VZ, Forgiarini Junior LA. Early mobilization: why, what for and how? Med Intensiva. 2017;41(7):429-36.

Jolley SE, Bunnell AE, Hough CL. ICU-acquired weakness. Chest. 2016;150(5):1129-40.

Lee M, Kang J, Jeong YJ. Risk factors for post-intensive care syndrome: a systematic review and meta-analysis. Aust Crit Care. 2020;33(3):287-94.

Colbenson GA, Johnson A, Wilson ME. Post-intensive care syndrome: impact, prevention, and management. Breathe. 2019;15(2):98-101.

Kemp HI, Corner E, Colvin LA. Chronic pain following COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436-40.

Koh GC, Hoenig H. How should the rehabilitation community prepare for 2019-nCoV? Arch Phys Med Rehabil. 2020;101(6):1068-71.

Stam HJ, Stucki G, Bickenbach J. Covid-19 and post intensive care syndrome: a call for action. J Rehabil Med. 2020;52(4):jrm00044.

Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19(1):274.

Zorowitz RD. ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management. Chest. 2016;150(4):966-71.

Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, et al. Post‐intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6(3):233-46.

Smith JM, Lee AC, Zeleznik H, Scott JP, Fatima A, Needham DM, et al. Home and community-based physical therapist management of adults with post-intensive care syndrome. Phys Ther. 2020;100(7):1062-73.

Published

2022-08-24

How to Cite

The physiotherapist’s role in the SARS-CoV-2 pandemic. (2022). Saúde & Tecnologia, T3, e29-e33. https://doi.org/10.25758/set.2271